z-logo
Premium
Beyond Farnesoid X receptor to target new therapies for NAFLD
Author(s) -
Liu Xiaoying,
Green Richard M.
Publication year - 2017
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.29411
Subject(s) - farnesoid x receptor , medicine , nonalcoholic fatty liver disease , obeticholic acid , endocrinology , lipogenesis , small heterodimer partner , insulin resistance , bile acid , fatty liver , steatosis , hepatology , steatohepatitis , glucose homeostasis , lipid metabolism , nuclear receptor , biology , insulin , agonist , receptor , biochemistry , transcription factor , disease , gene

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom